Related Experiment Video
Updated: May 8, 2026
07:56
Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Metabolic and clinical consequences of hyperthyroidism on bone density
Jagoda Gorka1, Regina M Taylor-Gjevre, Terra Arnason
1Department of Medicine, University of Saskatchewan, Saskatoon, Canada S7N 0W8.
International Journal of Endocrinology
|August 24, 2013
Summary
Hyperthyroidism accelerates bone loss and increases fracture risk, particularly in postmenopausal women. Effective treatment of thyroid disorders is crucial for managing osteoporosis and improving bone health.
Area of Science:
- Endocrinology
- Bone Metabolism
- Osteoporosis Research
Background:
- The link between hyperthyroidism and osteoporosis was first noted in 1891.
- Bone mineral density (BMD) loss is a known consequence of overt and subclinical hyperthyroidism.
- Effective medical treatments for hyperthyroidism may mask its impact on bone health, leading to underrecognition.
Purpose of the Study:
- To review current knowledge on how hyperthyroidism affects bone metabolism.
- To explore the mechanisms of thyroid hormones on bone.
- To examine clinical outcomes, including BMD and fracture risk, in hyperthyroid patients.
Main Methods:
- Literature review focusing on recent publications.
- Analysis of studies investigating thyroid hormone action on bone.
- Examination of clinical data on BMD and fracture risk in hyperthyroid individuals.
Main Results:
- Thyroid hormones significantly impact bone metabolism, influencing bone turnover.
- Hyperthyroidism is associated with reduced BMD and increased fracture risk.
- Menopausal status and sex influence the clinical presentation and outcomes of thyroid disease on bone.
Conclusions:
- Hyperthyroidism poses a significant risk to bone health, contributing to osteoporosis.
- Understanding the mechanisms and clinical consequences is vital for patient management.
- Treatment of hyperthyroidism can mitigate bone loss and reduce fracture risk.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...